A multicomponent indicator ticket for presumptive field identification of hazardous materials
Award amount
$149,798Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- Clear Scientific, LLC
- Proposal award date
- 2017-06-01
- Contract end date
- 2019-02-23
- UEI
- USCME5Z4GVN7
- Solicitation number
- 17.1
- Topic code
- A17-063
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine
- Stable Antimicrobial Formulation of Scopolamine for Multi-dose Vial
- Stable Antimicrobial Formulation of Scopolamine for Multi-dose Vial
- An oral therapeutic to treat intoxication by prescription and illicit stimulants
- Dual Formulation of Atropine/Scopolamine with Enhanced Stability
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Chemical, Biological, and Explosives Indicator Ticket
- A multicomponent indicator ticket for presumptive field identification of hazardous materials
- Comprehensive Chemical, Biological, and Explosives Indicator Ticket Platform for Rapid Field Identification of Threats
- Multiplexed Chemical, Biological, and Explosive Indicator Ticket
- Comprehensive Chemical, Biological, and Explosives Indicator Ticket Platform for Rapid Field Identification of Threats
Research funding history
19 SBIR/STTR records share this UEI (2017–2024). Reported award amounts total $10,849,675. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services